Results 1 to 10 of about 747,119 (356)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk! [PDF]

open access: yesMedicina, 2023
Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice.
Rita Carlotta Santoro   +3 more
doaj   +2 more sources

The role of hemostatic changes in the pathogenesis of diabetic retinopathy [PDF]

open access: yesJournal of Education, Health and Sport, 2022
Introduction: The paper presents the results of the hemostasis system of rats with experimental diabetic retinopathy. Material and methods: Experimental studies were performed on white Wistar rats, which were divided into 2 groups: 1st group – intact
Nataliya Preys, Ivan Savytskyi
doaj   +3 more sources

CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [PDF]

open access: yesJournal of Multidisciplinary Healthcare
Fanchun Yang, Qingying Wang, Rui Ma, Fangzhen Deng, Jie Liu Department of Obstetrics and Gynecology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence: Jie Liu, Department of ...
Yang F, Wang Q, Ma R, Deng F, Liu J
doaj   +2 more sources

CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [Letter] [PDF]

open access: yesJournal of Multidisciplinary Healthcare
Zainarda,1,2,* Hasta Handayani Idrus3,* 1Faculty of Medicine, Hasanuddin University, Makassar, Indoensia; 2Department of Orthopedic, Dody Sarjoto Hospital, Makassar, Indoensia; 3Biomedical Research Center, Research Organization for Health ...
Zainarda, Idrus HH
doaj   +2 more sources

Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients. [PDF]

open access: yesPLoS ONE, 2022
BackgroundCOVID-19 is a viral disease caused by a new strain of corona virus. Currently, prognosis and risk stratification of COVID-19 patients is done by the disease's clinical presentation.
Esayas Tekle   +8 more
doaj   +2 more sources

The partial thromboplastin (cephalin) time test [PDF]

open access: bronzeJournal of Clinical Pathology, 1972
Nine partial thromboplastin (cephalin) reagents have been compared in a parallel investigation of groups of patients on `long-term' anticoagulants, a group with moderate haemophilia, and patients on heparin infusion.Results with the seven commercial reagents and a human cephalin extract have been correlated with those of a specially prepared and ...
L. Poller, J M Thomson
openalex   +5 more sources

The multiple faces of the partial thromboplastin time APTT [PDF]

open access: bronzeJournal of Thrombosis and Haemostasis, 2004
Samuel I. Rapaport   +7 more
  +11 more sources

Potential Anticoagulant Activity of Thymus atlanticus Leaves Part in vitro on Normal Plasma Samples [PDF]

open access: yesInternational Journal of Biomedicine, 2022
The purpose of this study was to evaluate the anticoagulant activity of Thymus atlanticus leaves. Methods and Results: This cross-sectional study was carried out in Khartoum state from March 2021 to June 2021. This study comprised 60 healthy volunteers (
Mothana Abdullah Elhussein   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy